BTS
NVO

BB&T Securities’s Novo Nordisk NVO Stock Holding History

BB&T Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$5.4M Sell
209,294
-300,602
-59% -$7.6M 0.05% 379
2019
Q2 		$13M Buy
509,896
+1,440
+0.3% +$35.6K 0.12% 228
2019
Q1 		$13.3M Sell
508,456
-41,016
-7% -$1.01M 0.13% 218
2018
Q4 		$12.7M Sell
549,472
-42,276
-7% -$939K 0.14% 197
2018
Q3 		$13.9M Buy
591,748
+8,904
+2% +$217K 0.14% 211
2018
Q2 		$13.4M Buy
582,844
+40,350
+7% +$959K 0.14% 200
2018
Q1 		$13.4M Buy
542,494
+42,032
+8% +$1.1M 0.15% 189
2017
Q4 		$13.4M Sell
500,462
-95,060
-16% -$2.42M 0.17% 157
2017
Q3 		$14.3M Sell
595,522
-6,222
-1% -$141K 0.19% 140
2017
Q2 		$12.9M Buy
601,744
+38,034
+7% +$767K 0.19% 150
2017
Q1 		$9.66M Buy
563,710
+350,596
+165% +$6.1M 0.13% 196
2016
Q4 		$4.43M Hold
213,114
– – 0.06% 294
2016
Q3 		$4.43M Buy
213,114
+16,280
+8% +$404K 0.07% 290
2016
Q2 		$5.29M Buy
196,834
+59,724
+44% +$1.64M 0.08% 259
2016
Q1 		$3.71M Sell
137,110
-5,888
-4% -$158K 0.06% 291
2015
Q4 		$4.15M Buy
142,998
+11,348
+9% +$314K 0.09% 222
2015
Q3 		$3.57M Buy
131,650
+4,498
+4% +$127K 0.08% 231
2015
Q2 		$3.48M Sell
127,152
-38,486
-23% -$1.08M 0.07% 240
2015
Q1 		$4.42M Buy
165,638
+2,554
+2% +$58.8K 0.1% 184
2014
Q4 		$3.45M Buy
163,084
+4,856
+3% +$108K 0.08% 213
2014
Q3 		$3.77M Buy
158,228
+1,600
+1% +$36.8K 0.09% 198
2014
Q2 		$3.62M Buy
156,628
+39,568
+34% +$874K 0.09% 208
2014
Q1 		$2.67M Buy
117,060
+3,970
+4% +$84.6K 0.07% 222
2013
Q4 		$2.09M Buy
113,090
+14,330
+15% +$250K 0.06% 246
2013
Q3 		$1.67M Buy
98,760
+13,100
+15% +$220K 0.05% 255
2013
Q2 		$1.33M Buy
+85,660
New +$1.43M 0.04% 269

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BB&T Securities's NVO Position: Q3 2019 in Review

BB&T Securities reduced its Novo Nordisk (NVO) stake by 59% in Q3 2019, selling an estimated $7.6M and leaving 209,294 shares worth $5.4M. The position accounts for 0.05% of the portfolio, ranked #379.

BB&T Securities first reported a position in NVO in Q2 2013 and has held it in 26 quarters since. The position peaked at $14.3M in Q3 2017. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

  • BB&T Securities held 209,294 shares of Novo Nordisk worth $5.4M as of Q3 2019.
  • BB&T Securities sold 300,602 Novo Nordisk shares in Q3 2019, an estimated $7.6M.
  • Novo Nordisk made up 0.05% of BB&T Securities's portfolio in Q3 2019, its #379 holding.
  • BB&T Securities first reported a position in Novo Nordisk in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's Novo Nordisk position peaked at $14.3M in Q3 2017.
  • 564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.